文献速递乳腺癌放疗

乳腺癌放疗急性皮肤毒性预测因素:分次方案与治疗体积的作用

Predictors of radiation-induced acute skin toxicity in breast cancer at a single institution: Role of fractionation and treatment volume.
PubMed 文献 · Adv Radiat Oncol · 2017-11-06

该单中心回顾性研究评估了280例乳腺癌术后辅助放疗患者≥2级皮炎和湿性脱皮的发病率,分析了放疗靶区、分次方案和BMI的作用。结果显示乳房切除术后放疗患者湿性脱皮率最高(24%),保乳患者中常规分次湿性脱皮率(10.9%)高于大分割(1.8%;P = .05),化疗和区域淋巴结照射也是湿性脱皮的显著预测因素。

要点

  • 乳房切除术后放疗患者湿性脱皮率最高(24%),保乳患者为8.7%。
  • 保乳患者中常规分次湿性脱皮率10.9%,高于大分割的1.8%(P = .05)。
  • 化疗(OR 3.74;P = .04)和区域淋巴结照射(OR 3.29;P = .03)是保乳患者湿性脱皮的显著预测因素。

核心结论

  • 乳房切除术后放疗和常规分次方案是急性皮肤毒性的风险因素。
  • BMI升高、区域淋巴结照射和化疗使用与湿性脱皮风险增加相关。
  • 在高风险患者中需探索使用毒性更低的大分割方案。

研究设计与样本

  • 单中心回顾性研究,纳入280例乳腺癌术后接受辅助放疗的患者。
  • 收集患者人口学、疾病和治疗特征以及急性皮肤毒性信息。
  • 使用多因素逻辑回归模型评估≥2级皮炎和湿性脱皮的预测因素。

主要发现

  • 乳房切除术后放疗患者湿性脱皮率最高(24%)。
  • 保乳患者湿性脱皮率为8.7%,其中常规分次组为10.9%,大分割组为1.8%(P = .05)。
  • 保乳患者中化疗(OR 3.74;P = .04)和区域淋巴结照射(OR 3.29;P = .03)是湿性脱皮的显著预测因素。
  • 尽管保乳患者平均BMI升高,大分割治疗仍导致较低的皮肤毒性率。

关键数值与推荐

  • 保乳患者常规分次湿性脱皮率10.9%,大分割为1.8%(P = .05)。
  • 化疗的OR为3.74(P = .04),区域淋巴结照射的OR为3.29(P = .03),均为保乳患者湿性脱皮的显著预测因素。

临床怎么用

  • 对高风险急性皮肤毒性患者(如高BMI和接受乳房切除术后放疗者)可考虑使用大分割方案。
  • 保乳患者接受化疗或区域淋巴结照射时需关注湿性脱皮风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The associations among radiation fractionation, body mass index (BMI), and acute skin toxicity with adjuvant radiation for breast cancer is of increasing interest. This study evaluated the rate of grade ≥2 dermatitis and moist desquamation (MD) in patients with a high BMI who were treated to the breast or chest wall to understand the role of radiation target, fractionation regimen, and BMI. METHODS AND MATERIALS: We retrospectively evaluated 280 patients treated with adjuvant radiation for breast cancer after up-front surgery. We collected information on patient demographics, disease and treatment characteristics, and acute skin toxicities. Multiple logistic regression models were used to evaluate for predictors of grade ≥2 dermatitis and MD. RESULTS: Patients undergoing post-mastectomy radiation therapy (PMRT) had the highest rate of MD (24%). The rate was lower (8.7%) among lumpectomy patients, but those receiving conventional fractionation had a higher rate of MD (10.9%) compared with hypofractionated therapy (1.8%; P = .05). Among lumpectomy patients, chemotherapy use (odds ratio, 3.74; P = .04) and regional nodal irradiation (odds ratio, 3.29; P = .03) were also significant predictors of MD. Despite an elevated average BMI among lumpectomy patients, hypofractionated therapy resulted in lower rates of skin toxicity. CONCLUSIONS: We identified multiple risk factors for acute skin toxicity, including the use of PMRT and conventionally fractionated regimens. Elevated BMI, regional nodal irradiation, and chemotherapy use were associated with an increased risk of MD. Our findings highlight the need to explore the use of less toxic hypofractionated regimens in patients who are at the highest risk of acute skin toxicity, including those with a higher BMI and those receiving PMRT.

来源:Adv Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Parekh A, Dholakia AD, Zabranksy DJ, et al. Predictors of radiation-induced acute skin toxicity in breast cancer at a single institution: Role of fractionation and treatment volume. Adv Radiat Oncol. 2017. PMID: 29556573. doi:10.1016/j.adro.2017.10.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。